BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 28471826)

  • 1. Chronic comorbidities associated with inflammatory bowel disease: prevalence and impact on healthcare costs in Switzerland.
    Bähler C; Schoepfer AM; Vavricka SR; Brüngger B; Reich O
    Eur J Gastroenterol Hepatol; 2017 Aug; 29(8):916-925. PubMed ID: 28471826
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trends in prevalence, mortality, health care utilization and health care costs of Swiss IBD patients: a claims data based study of the years 2010, 2012 and 2014.
    Bähler C; Vavricka SR; Schoepfer AM; Brüngger B; Reich O
    BMC Gastroenterol; 2017 Dec; 17(1):138. PubMed ID: 29197335
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Healthcare utilization and comorbidity burden among children and young adults in the United States with systemic lupus erythematosus or inflammatory bowel disease.
    Karve S; Candrilli S; Kappelman MD; Tolleson-Rinehart S; Tennis P; Andrews E
    J Pediatr; 2012 Oct; 161(4):662-670.e2. PubMed ID: 22578787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trends in health-care costs and utilization for inflammatory bowel disease from 2010 to 2014 in Korea: A nationwide population-based study.
    Kim JW; Lee CK; Rhee SY; Oh CH; Shim JJ; Kim HJ
    J Gastroenterol Hepatol; 2018 Apr; 33(4):847-854. PubMed ID: 29055148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of aging on healthcare costs of inflammatory bowel disease: a glimpse into the future.
    van der Have M; Mangen MJ; van der Valk ME; Smeets HM; van Bodegraven A; Dijkstra G; Fidder HH; de Jong DJ; Pierik M; Ponsioen CY; van der Meulen-de Jong AE; van der Woude CJ; van de Meeberg PC; Romberg-Camps MJ; Clemens CH; Jansen JM; Mahmmod N; Bolwerk CJ; Vermeijden JR; Siersema PD; Leenders M; Oldenburg B; ;
    Inflamm Bowel Dis; 2014 Apr; 20(4):637-45. PubMed ID: 24518606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Epidemiology and socio-economic aspects of chronic inflammatory bowel diseases in Switzerland].
    Schoepfer A; Safroneeva E
    Ther Umsch; 2019 Jan; 75(5):255-259. PubMed ID: 30700239
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Shifting Cost-drivers of Health Care Expenditures in Inflammatory Bowel Disease.
    Click B; Lopez R; Arrigain S; Schold J; Regueiro M; Rizk M
    Inflamm Bowel Dis; 2020 Jul; 26(8):1268-1275. PubMed ID: 31671186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Health Care Cost Analysis in a Population-based Inception Cohort of Inflammatory Bowel Disease Patients in the First Year of Diagnosis.
    Niewiadomski O; Studd C; Hair C; Wilson J; McNeill J; Knight R; Prewett E; Dabkowski P; Dowling D; Alexander S; Allen B; Tacey M; Connell W; Desmond P; Bell S
    J Crohns Colitis; 2015 Nov; 9(11):988-96. PubMed ID: 26129692
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Does the hospital cost of care differ for inflammatory bowel disease patients with or without gastrointestinal infections? A case-control study].
    Schmidt C; Köhler F; Kräplin T; Hartmann M; Lerch MM; Stallmach A
    Z Gastroenterol; 2014 Jul; 52(7):643-8. PubMed ID: 25026005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The in-hospital burden of hidradenitis suppurativa in patients with inflammatory bowel disease: a decade nationwide analysis from 2004 to 2014.
    Ramos-Rodriguez AJ; Timerman D; Khan A; Bonomo L; Hunjan MK; Lemor A
    Int J Dermatol; 2018 May; 57(5):547-552. PubMed ID: 29431201
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The health care cost of intravenous iron treatment in IBD patients depends on the economic evaluation perspective.
    Bager P; Dahlerup JF
    J Crohns Colitis; 2010 Oct; 4(4):427-30. PubMed ID: 21122539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Economic burden of patients with anemia in selected diseases.
    Ershler WB; Chen K; Reyes EB; Dubois R
    Value Health; 2005; 8(6):629-38. PubMed ID: 16283863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Direct health-care cost utilization in Hong Kong inflammatory bowel disease patients in the initial 2 years following diagnosis.
    Mak LY; Ng SC; Wong IOL; Li MKK; Lo FH; Wong MTL; Leung CM; Tsang SWC; Chan KH; Sze SF; Shan EHS; Lam BCY; Hui AJ; Hung IFN; Leung WK
    J Gastroenterol Hepatol; 2018 Jan; 33(1):141-149. PubMed ID: 28475813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost of outpatient care in patients with inflammatory bowel disease in a German University Hospital.
    Ebinger M; Leidl R; Thomas S; Von Tirpitz C; Reinshagen M; Adler G; Konig HH
    J Gastroenterol Hepatol; 2004 Feb; 19(2):192-9. PubMed ID: 14731130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A chronic care model significantly decreases costs and healthcare utilisation in patients with inflammatory bowel disease.
    Sack C; Phan VA; Grafton R; Holtmann G; van Langenberg DR; Brett K; Clark M; Andrews JM
    J Crohns Colitis; 2012 Apr; 6(3):302-10. PubMed ID: 22405166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inflammatory Bowel Disease and the Risk of Autoimmune Diseases.
    Wilson JC; Furlano RI; Jick SS; Meier CR
    J Crohns Colitis; 2016 Feb; 10(2):186-93. PubMed ID: 26507860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Opioid Use Is Associated With Higher Health Care Costs and Emergency Encounters in Inflammatory Bowel Disease.
    Alley K; Singla A; Afzali A
    Inflamm Bowel Dis; 2019 Nov; 25(12):1990-1995. PubMed ID: 31087042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Costs of ambulant care for patients with inflammatory bowel disease in general practice].
    Beiche A; König HH; Ebinger M; Matysiak-Klose D; Braun V; Leidl R
    Z Gastroenterol; 2003 Jun; 41(6):527-36. PubMed ID: 12806538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High end of life health care costs and hospitalization burden in inflammatory bowel disease patients: A population-based study.
    Murthy SK; James PD; Antonova L; Chalifoux M; Tanuseputro P
    PLoS One; 2017; 12(5):e0177211. PubMed ID: 28498877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased risk for coronary heart disease, asthma, and connective tissue diseases in inflammatory bowel disease.
    Haapamäki J; Roine RP; Turunen U; Färkkilä MA; Arkkila PE
    J Crohns Colitis; 2011 Feb; 5(1):41-7. PubMed ID: 21272803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.